Announcement on Convening Semi-annual and Q3 2024 Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening Semi-annual and Q3 2024 Performance Briefing
Filed with SSE · · 2 pages · Chinese
Release
Tibet Rhodiola Pharmaceutical Holding Co. on 6ix
Earlier from Tibet Rhodiola Pharmaceutical
- Announcement on Obtaining Approval for Drug Supplement Application for Imdur (Chinese Market)
- Announcement on Progress in Implementation of Significant Asset Restructuring
- Announcement on the Implementation of 2024 Semi-annual Equity Distribution
- Full Text of 2023 Semi-annual Report
- Announcement on Progress in Implementation of Significant Assets Reorganization
Later from Tibet Rhodiola Pharmaceutical
- Report for Q3 2024
- Report on the Implementation of Major Asset Purchase
- Announcement on the Convening of the Semi-annual and Q3 2024 Performance Briefing
- Announcement on Extension of Share Pledge by Shareholder with Over 5% Shares
- Announcement on the Profit Distribution Plan for Q3 2024
Follow Tibet Rhodiola Pharmaceutical into a list and get an email when it puts out news.
Follow Tibet Rhodiola Pharmaceutical